Skip to content

Angiotensin-(1-7) Research

Peer-reviewed studies from PubMed on Angiotensin-(1-7) mechanisms, clinical trials, and safety data. 3,594 total studies indexed.

Research Overview

3,594Total studies
0Human trials
0Systematic reviews
1Animal studies
◐ Moderate EvidenceEvidence level
20252026Date range
Arteriosclerosis, thrombosis, and vascular biologyPMID: 41711028

Preeclampsia, a condition characterized by new-onset hypertension during pregnancy and ≥1 indices of organ damage, is a major driver of both short- and long-term maternal health outcomes. Individuals with a history of preeclampsia are at increased risk for cardiovascular, renal, and other ...

View on PubMed
Metabolic brain diseasePMID: 41706377

Alzheimer's disease (AD) is characterized by progressive neurodegeneration marked by tau hyperphosphorylation, amyloid-beta (Aβ) buildup, neuroinflammation, and blood-brain barrier (BBB) dysfunction. Although much attention is paid to understanding amyloid and tau pathologies, there are sti...

View on PubMed
Hypertension (Dallas, Tex. : 1979)PMID: 41705339

Angiotensin-(1-7) lowers blood pressure and improves metabolic outcomes in animal models of obesity and hypertension. Whether central mechanisms are involved in these protective cardiometabolic effects is poorly understood. In this study, we hypothesized that angiotensin-(1-7) engages central neu...

View on PubMed
NeuropharmacologyPMID: 41698644

Diminazene (DIZE), an agonist of the Ang-(1-7) system, has been proven to suppress astrocytic neuroinflammatory responses in Alzheimer's disease (AD). NADPH oxidase 4 (NOX4) is abundantly expressed in astrocytes and critically mediates oxidative stress damage and ferroptosis. However, the mode of...

View on PubMed
MitochondrionPMID: 41687755

Manifesting initially as a physiological adaptation to pressure/volume overload, cardiac hypertrophy helps to maintain normal cardiac output via optimal mitochondrial function. However, chronic hypertension leads to pathological cardiac hypertrophy that is characterized by compromised cardiac out...

View on PubMed
Intensive care medicine experimentalPMID: 41663785

The renin-angiotensin system (RAS) plays a critical role in vascular homeostasis and inflammation, and its dysregulation has been implicated in the pathophysiology of COVID-19. We investigated the dynamics of RAS peptides and markers of endothelial dysfunction in relation to respiratory disease p...

View on PubMed
NeurosciencePMID: 41654102

This study explores the anatomical distribution of Angiotensin-(Ang)-(1-7) fusion protein within the central nervous system of the novel transgenic rat model (TG7371). The Ang-(1-7)/Mas pathway of the renin-angiotensin system (RAS) plays a key role in cardiovascular regulation and influences high...

View on PubMed
Food research international (Ottawa, Ont.)PMID: 41652705

Hypertension, a major global health issue, is closely associated with the overactivation of angiotensin-converting enzyme (ACE). Food-derived ACE inhibitory peptides are gaining increasing attention as natural alternatives to synthetic antihypertensive drugs due to their safety and efficacy. In t...

View on PubMed
Scientific reportsPMID: 41644575

Hypoxia induced-pulmonary hypertension (HPH) is a life-threatening cardiovascular disorder prevalent in high-altitude regions. Right ventricular (RV) function and RV—pulmonary arterial (RV—PA) coupling are key to patient prognosis. Perillyl alcohol (POH), a natural compound, holds p...

View on PubMed
Rheumatology internationalPMID: 41642365

The renin-angiotensin system (RAS), traditionally regarded as a hormonal cascade regulating cardiovascular and renal homeostasis, is increasingly recognized as a locally active, tissue-specific network within joint structures. Accumulating evidence indicates that synovial tissue, synovial fluid, ...

View on PubMed
BiomedicinesPMID: 41595635

Overactivation of the renin-angiotensin-aldosterone system (RAAS) promotes haemodynamic overload, inflammation, and fibrosis in the heart and kidneys. Recently, sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as a cornerstone therapy in cardiorenal protection. Emerging data indicat...

View on PubMed
International immunopharmacologyPMID: 41581243

Gentamicin (Genta) is a widely used aminoglycoside antibiotic, but its clinical value is limited by nephrotoxicity involving oxidative stress, inflammation, apoptosis, and dysregulation of the ADAM-17/ACE2/Ang (1-7)/MasR axis. β-Sitosterol (BSST) is a phytosterol with reported antioxidant a...

View on PubMed
Journal of proteomicsPMID: 41570893

Angiotensin-(1-7) [Ang-(1-7)] is a heptapeptide of the renin-angiotensin system (RAS) with antitumoral effects reported in various tumoral cell lines, including the human lung adenocarcinoma A549 lineage. While previous studies have shown that Ang-(1-7) modulates MAPK and PI3K-AKT signaling, the ...

View on PubMed
Frontiers in immunologyPMID: 41567221

Since the emergence of SARS-CoV-2 in late 2019, substantial efforts have been made to understand its mechanisms of pathogenicity. Although angiotensin-converting enzyme 2 (ACE2) has been identified as the main receptor for viral entry, the complexity of the host immune response to different Spike...

View on PubMed
Physiological researchPMID: 41532628

Combined renin-angiotensin system (RAS) inhibition can enhance blood pressure control but has not improved clinical outcomes, underscoring the importance of complex changes in angiotensin peptide profiles in combined RAS blockade. We investigated hemodynamics and circulating and tissue angiotensi...

View on PubMed
Physiological researchPMID: 41532626

SARS-CoV-2 engages ACE2 for cell entry, perturbing the counter-regulatory ACE2/Ang-(1-7)/Mas axis and shifting the renin angiotensin system toward ACE/Ang II/AT1 signaling, with a concomitant reduction in nitric oxide (NO) bioavailability. NO sits at the crossroads of these pathways, acting both ...

View on PubMed
BMC infectious diseasesPMID: 41527037

Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin aldosterone system (RAAS), is the main receptor for SARS-CoV-2 entry into human cells. The occurrence of long-term symptoms post-COVID 19 infection (Long COVID, LC) is an important public health issue with an unclear eti...

View on PubMed
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyPMID: 41524292

Non-alcoholic fatty liver disease (NAFLD) is a global health burden characterized by hepatic steatosis and progressive fibrosis, necessitating novel therapeutic strategies. This study investigates the molecular mechanism by which cyclic RGD peptide (cRGD)-modified adipose-derived mesenchymal stem...

View on PubMed

Disclaimer: This page aggregates research from PubMed for educational purposes only. Inclusion of a study does not imply endorsement of its findings. Always consult a qualified healthcare professional before making decisions based on research literature.